Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 1760 for cancer

Edit search filters
  1. Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program

    Jacksonville, FL

  2. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer

    Rochester, MN

  3. A Phase 1b/2 Study Of Onvansertib (PCM-075) In Combination With FOLFIRI And Bevacizumab For Second-Line Treatment Of Metastatic Colorectal Cancer in Patients With A KRAS Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia

    Rochester, MN

  5. A Study To Evaluate The Safety And Effectiveness Of Lisocatagene Maraleucel In Patients

    Jacksonville, FL, Rochester, MN

  6. Safety And Preliminary Efficacy Assessment Of AZD7789 In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma

    Rochester, MN

  7. A Study To Evaluate Optune Vs. Prophylactic Cranial Irradiation (PCI) In Non-Small Cell Lung Cancer Patients

    Scottsdale/Phoenix, AZ

  8. A Phase 2 Study Of CPI-0610 With And Without Ruxolitinib In Patients With Myelofibrosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Assess Dendritic Cell Immunotherapy Plus Standard-of-Care To Treat Advanced Renal Cell Carcinoma

    Rochester, MN

.

Mayo Clinic Footer